Power Market Access in Pharma
From evidence to commercial success, navigate the complexities of value and market access strategy with confidence and precision.
Navigate the shifting market access landscape
Securing market access is more complex than ever. A convergence of scientific, regulatory, economic, and policy pressures – all happening simultaneously across global healthcare systems – is reshaping the access landscape.
Payers are demanding stronger evidence of clinical outcomes and real-world effectiveness. Health systems are shifting toward value-based care. International policy developments – like Most Favored Nation pricing models – are redefining global pricing dynamics. At the same time, technology is transforming how data drives decisions, from real-world evidence to AI-enabled analytics. For life sciences companies, the ability to navigate this evolving environment is critical – not just to launch success, but to long-term impact.
At Deloitte, we help you anticipate, adapt, and stay ahead. With a deep understanding of what matters to payers, providers, and patients, we work across the product lifecycle to shape strategies that unlock access – efficiently, sustainably, and globally.
Access is not a checkpoint – it’s a mindset. And it starts well before launch.
Partner with us to address critical success milestones in your market access journey:
Why partner with us?
We bring together strategy, science, and deep stakeholder insight to deliver measurable access success.
What sets us apart:
- Leading market access practices with a track record of success across TAs and geographies.
- Global network of experts, with local insights across major and emerging market.
- Cross-functional expertise that connects access with medical and commercial strategies.
- Tech-enabled solutions that accelerate scenario planning and payer insight synthesis.
- Tailored, lifecycle-spanning support from early asset evaluation to post-launch optimisation.
Our Thinking
How we bridge innovation, evidence and patient access. We believe that future-ready access strategies are:
- Proactive – planned early and refined often
- Evidence-driven – grounded in real-world impact
- Locally informed – tailored to payer realities across geographies
- Integrated – aligned with clinical, commercial, and corporate goals
- Tech-enabled – powered by AI, data platforms, digital insights to act smarter
Success lies not in checking regulatory boxes, but in building credible, compelling value stories that resonate across the healthcare ecosystem. Explore our thinking and uncover the latest perspectives on aligning value, evidence, and patient access.
Explore more
Alexander Mirow
Thibault Ducarme
